Skip to main content

Lakefront Biotherapeutics NV 6-K, filed Nov 4, 2026

Lakefront Biotherapeutics NV (LKFT)

6-K 2026-11-04 For: 2026-11-04
View Original
Added on November 04, 2026

About this 6-K

Lakefront Biotherapeutics NV filed this 6-K on November 4, 2026.

Lakefront Biotherapeutics NV reported preliminary data from 33 patients: 18/20 (90%) ITP patients responded, and all 9 response-evaluable AIHA patients responded; 15 and 8 responders, respectively, had ongoing responses. AI summary